Facts, Fancies and Follies of Drug-induced QT/QTc Interval Shortening
Overview
Authors
Affiliations
Wang M, Ma Y, Shen Z, Jiang L, Zhang X, Wei X Front Psychiatry. 2022; 13:925583.
PMID: 35873271 PMC: 9300900. DOI: 10.3389/fpsyt.2022.925583.
Ucpinar S, Darpo B, Neale A, Nunn P, Shu J, Chu K Clin Transl Sci. 2022; 15(6):1507-1518.
PMID: 35301810 PMC: 9199881. DOI: 10.1111/cts.13271.
Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers.
Taubel J, Lorch U, Spencer C, Freier A, Camilleri D, Djumanov D Sci Rep. 2021; 11(1):6404.
PMID: 33739022 PMC: 7973531. DOI: 10.1038/s41598-021-85650-3.
Mu S, Darpo B, Tang Z, Novotny W, Tawashi M, Xue H Clin Transl Sci. 2020; 13(5):923-931.
PMID: 32144955 PMC: 7485941. DOI: 10.1111/cts.12779.
Drug-Induced QT/QTc Interval Shortening: Lessons from Drug-Induced QT/QTc Prolongation.
Malik M Drug Saf. 2016; 39(7):647-59.
PMID: 26968542 DOI: 10.1007/s40264-016-0411-3.